Clinical Pathology

Boston - June 30, 2025  -  PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight®...

Lumea's Viewer+™ digital pathology platform was selected by GI Alliance, a top US GI network, to enhance diagnostic efficiency and workflow nationwide. LEHI, UT, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- GI Alliance, the leading...

Recognition underscores the impact of Proscia in advancing precision medicine from drug discovery to diagnostics PHILADELPHIA — June 3, 2025 — Proscia®, a software company accelerating pathology’s transition to digital and AI, today...

From the Aiosyn Blog IVDR represents a significant overhaul of regulations requiring more rigorous oversight, clinical validation assessed by a Notified Body, and stricter post-market surveillance (PMS). Aiosyn’s AI-powered...

"The main business of humanity is to do a good job of being human beings," said Paul, "not to serve as appendages to machines, institutions, and systems." If you have not read Player Piano, it is a good read. I read it many years ago...

New from the Proscia blog: Digital pathology has evolved far beyond improving quality and efficiency. It’s becoming a strategic gateway to business growth. This was the central message our CEO David West delivered during his breakout...